Skip to main content
Erschienen in: Annals of Behavioral Medicine 2/2015

01.04.2015 | Invited Commentary

Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub

verfasst von: Kristen Underhill, D. Phil., J. D.

Erschienen in: Annals of Behavioral Medicine | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Excerpt

As evidence grows for the effectiveness of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention [16], complementary research on PrEP acceptability [7] and uptake [813] has gained prominence. In the USA, PrEP acceptability research has largely focused on men who have sex with men (MSM) [14], given the sustained burden of HIV incidence in this group [15]. Although this work has identified many individual factors associated with willingness to use PrEP, emerging research has also examined PrEP acceptability in light of MSM partnership dynamics [1619]. Focusing on dyads is imperative: at least one third of HIV infections among US MSM occur within primary partnerships [20, 21], and relationship dynamics—including intimacy, commitment, and other interpersonal factors—demonstrably influence both HIV risk and protective behaviors [22, 23]. For example, prior studies report that many MSM in primary partnerships engage in condomless sex to express intimacy, and condom nonuse may be motivated by the desire to preserve these intimacy benefits [2427]. …
Literatur
1.
Zurück zum Zitat Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.CrossRefPubMedCentralPubMed Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363:2587-2599.CrossRefPubMedCentralPubMed
2.
Zurück zum Zitat Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410.CrossRefPubMedCentralPubMed Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367:399-410.CrossRefPubMedCentralPubMed
3.
Zurück zum Zitat Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.CrossRefPubMed Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367:423-434.CrossRefPubMed
4.
Zurück zum Zitat Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083-2090.CrossRefPubMed Choopanya K, Martin M, Suntharasamai P, et al. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial. Lancet. 2013;381:2083-2090.CrossRefPubMed
5.
Zurück zum Zitat Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012, 4:151ra125. Anderson PL, Glidden DV, Liu A, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012, 4:151ra125.
6.
Zurück zum Zitat Donnell D, Baeten JM, Bumpus NN, et al. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. J Acquir Immune Defic Syndr. 2014. Donnell D, Baeten JM, Bumpus NN, et al. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention. J Acquir Immune Defic Syndr. 2014.
7.
Zurück zum Zitat Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195-216.CrossRefPubMedCentralPubMed Young I, McDaid L. How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: a review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS Behav. 2014;18:195-216.CrossRefPubMedCentralPubMed
8.
Zurück zum Zitat Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11:e1001613.CrossRefPubMedCentralPubMed Liu A, Cohen S, Follansbee S, et al. Early experiences implementing pre-exposure prophylaxis (PrEP) for HIV prevention in San Francisco. PLoS Med. 2014;11:e1001613.CrossRefPubMedCentralPubMed
9.
Zurück zum Zitat Bush S, Rawlings K, Ng L, Mera R. Regional differences in the utilization of Truvada for PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 353. Bush S, Rawlings K, Ng L, Mera R. Regional differences in the utilization of Truvada for PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 353.
10.
Zurück zum Zitat Mera R, Rawlings K, Pechonkina A, et al. Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO, 2013, Abstract H-663a. Mera R, Rawlings K, Pechonkina A, et al. Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis. 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy. Denver, CO, 2013, Abstract H-663a.
11.
Zurück zum Zitat Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014. Grant RM, Anderson PL, McMahan V, et al. Uptake of pre-exposure prophylaxis, sexual practices, and HIV incidence in men and transgender women who have sex with men: a cohort study. Lancet Infect Dis. 2014.
12.
Zurück zum Zitat Ndase P, Celum C, Campbell J, et al. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Partners PrEP study experience. J Acquir Immune Defic Syndr. 2014;66:206-212.PubMed Ndase P, Celum C, Campbell J, et al. Successful discontinuation of the placebo arm and provision of an effective HIV prevention product after a positive interim efficacy result: the Partners PrEP study experience. J Acquir Immune Defic Syndr. 2014;66:206-212.PubMed
13.
Zurück zum Zitat King HL, Keller SB, Giancola MA, et al. Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study). AIDS Behav. 2014;18:1722-1725.CrossRefPubMed King HL, Keller SB, Giancola MA, et al. Pre-Exposure Prophylaxis Accessibility Research and Evaluation (PrEPARE Study). AIDS Behav. 2014;18:1722-1725.CrossRefPubMed
14.
Zurück zum Zitat Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166-170.PubMed Holt M. HIV pre-exposure prophylaxis and treatment as prevention: a review of awareness and acceptability among men who have sex with men in the Asia-Pacific region and the Americas. Sex Health. 2014;11:166-170.PubMed
15.
Zurück zum Zitat CDC: HIV among gay and bisexual men. Atlanta, GA: U.S. Dept of Health and Human Services, 2014. CDC: HIV among gay and bisexual men. Atlanta, GA: U.S. Dept of Health and Human Services, 2014.
16.
Zurück zum Zitat Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43:99-106.CrossRefPubMed Mimiaga MJ, Closson EF, Kothary V, Mitty JA. Sexual partnerships and considerations for HIV antiretroviral pre-exposure prophylaxis utilization among high-risk substance using men who have sex with men. Arch Sex Behav. 2014;43:99-106.CrossRefPubMed
17.
Zurück zum Zitat Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7:e50061.CrossRefPubMedCentralPubMed Saberi P, Gamarel KE, Neilands TB, et al. Ambiguity, ambivalence, and apprehensions of taking HIV-1 pre-exposure prophylaxis among male couples in San Francisco: a mixed methods study. PLoS One. 2012;7:e50061.CrossRefPubMedCentralPubMed
18.
Zurück zum Zitat Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.CrossRefPubMedCentralPubMed Brooks RA, Kaplan RL, Lieber E, et al. Motivators, concerns, and barriers to adoption of preexposure prophylaxis for HIV prevention among gay and bisexual men in HIV-serodiscordant male relationships. AIDS Care. 2011;23:1136-1145.CrossRefPubMedCentralPubMed
19.
Zurück zum Zitat Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26:87-94.CrossRefPubMedCentralPubMed Brooks RA, Landovitz RJ, Kaplan RL, et al. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDS. 2012;26:87-94.CrossRefPubMedCentralPubMed
20.
Zurück zum Zitat Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.CrossRefPubMedCentralPubMed Goodreau SM, Carnegie NB, Vittinghoff E, et al. What drives the US and Peruvian HIV epidemics in men who have sex with men (MSM)? PLoS One. 2012;7:e50522.CrossRefPubMedCentralPubMed
21.
Zurück zum Zitat Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.CrossRefPubMed Sullivan PS, Salazar L, Buchbinder S, Sanchez TH. Estimating the proportion of HIV transmissions from main sex partners among men who have sex with men in five US cities. AIDS. 2009;23:1153-1162.CrossRefPubMed
22.
Zurück zum Zitat Burton J, Darbes L, Operario D. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of the evidence. AIDS Behav. 2010;14:1-10.CrossRefPubMedCentralPubMed Burton J, Darbes L, Operario D. Couples-focused behavioral interventions for prevention of HIV: Systematic review of the state of the evidence. AIDS Behav. 2010;14:1-10.CrossRefPubMedCentralPubMed
24.
Zurück zum Zitat Hoff CC, Chakravarty D, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738-745.CrossRefPubMedCentralPubMed Hoff CC, Chakravarty D, Beougher SC, Neilands TB, Darbes LA. Relationship characteristics associated with sexual risk behavior among MSM in committed relationships. AIDS Patient Care STDs. 2012;26:738-745.CrossRefPubMedCentralPubMed
25.
Zurück zum Zitat Darbes LA, Chakravarty D, Neilands TB, Beougher SC, Hoff CC. Sexual risk for HIV among gay male couples: a longitudinal study of the impact of relationship dynamics. Arch Sex Behav. 2014;43:47-60.CrossRefPubMed Darbes LA, Chakravarty D, Neilands TB, Beougher SC, Hoff CC. Sexual risk for HIV among gay male couples: a longitudinal study of the impact of relationship dynamics. Arch Sex Behav. 2014;43:47-60.CrossRefPubMed
26.
Zurück zum Zitat Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014;43:73-87.CrossRefPubMedCentralPubMed Greene GJ, Andrews R, Kuper L, Mustanski B. Intimacy, monogamy, and condom problems drive unprotected sex among young men in serious relationships with other men: a mixed methods dyadic study. Arch Sex Behav. 2014;43:73-87.CrossRefPubMedCentralPubMed
27.
Zurück zum Zitat Golub SA, Starks TJ, Payton G, Parsons JT. The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. AIDS Behav. 2012;16:626-632.CrossRefPubMedCentralPubMed Golub SA, Starks TJ, Payton G, Parsons JT. The critical role of intimacy in the sexual risk behaviors of gay and bisexual men. AIDS Behav. 2012;16:626-632.CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Gamarel KE, Golub SA: Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships. Ann Behav Med. 2014. doi:10.1007/s12160-014-9646-3. Gamarel KE, Golub SA: Intimacy Motivations and Pre-exposure Prophylaxis (PrEP) Adoption Intentions Among HIV-Negative Men Who Have Sex with Men (MSM) in Romantic Relationships. Ann Behav Med. 2014. doi:10.​1007/​s12160-014-9646-3.
29.
Zurück zum Zitat Gilmore H, Koester K, Liu A, et al. To take or not to take PrEP: Perspectives from participants enrolled in the iPrEx Open Label Extension (OLE) in the United States. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 440. Gilmore H, Koester K, Liu A, et al. To take or not to take PrEP: Perspectives from participants enrolled in the iPrEx Open Label Extension (OLE) in the United States. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 440.
30.
Zurück zum Zitat Koester K, Amico KR, Liu A, et al. Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. XX International AIDS Conference. Melbourne, Australia, 2014, Abstract TUAC0102. Koester K, Amico KR, Liu A, et al. Sex on PrEP: qualitative findings from the iPrEx open label extension (OLE) in the US. XX International AIDS Conference. Melbourne, Australia, 2014, Abstract TUAC0102.
31.
Zurück zum Zitat Patel V, Estabrook S, Smith K, Golub S, et al. Motivators and concerns for adopting pre-exposure prophylaxis in men who have sex with men using mobile dating "apps" in New York City. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 434. Patel V, Estabrook S, Smith K, Golub S, et al. Motivators and concerns for adopting pre-exposure prophylaxis in men who have sex with men using mobile dating "apps" in New York City. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 434.
32.
Zurück zum Zitat Underhill K, Morrow K, Operario D, et al. Project PrEP Talk: An in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, D.C., USA, 2012, Abstract TUPD0306. Underhill K, Morrow K, Operario D, et al. Project PrEP Talk: An in-depth qualitative analysis of PrEP acceptability, expectations and risk compensation beliefs among United States MSM. XIX International AIDS Conference. Washington, D.C., USA, 2012, Abstract TUPD0306.
33.
Zurück zum Zitat Corneli A, Perry B, Kawango Agot, et al. Participant Explanations for Study Product Adherence in FEM-PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 366. Corneli A, Perry B, Kawango Agot, et al. Participant Explanations for Study Product Adherence in FEM-PrEP. 9th International Conference on HIV Treatment and Prevention Adherence. Miami, FL, 2014, Abstract 366.
34.
Zurück zum Zitat Jiwatram-Negron T, El-Bassel N: Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions. AIDS Behav. 2014. Jiwatram-Negron T, El-Bassel N: Systematic Review of Couple-Based HIV Intervention and Prevention Studies: Advantages, Gaps, and Future Directions. AIDS Behav. 2014.
35.
Zurück zum Zitat Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.CrossRefPubMed Remien RH, Stirratt MJ, Dolezal C, et al. Couple-focused support to improve HIV medication adherence: a randomized controlled trial. AIDS. 2005;19:807-814.CrossRefPubMed
36.
Zurück zum Zitat Wu E, El-Bassel N, McVinney LD, et al. Feasibility and promise of a couple-based HIV/STI preventive intervention for methamphetamine-using, black men who have sex with men. AIDS Behav. 2011;15:1745-1754.CrossRefPubMed Wu E, El-Bassel N, McVinney LD, et al. Feasibility and promise of a couple-based HIV/STI preventive intervention for methamphetamine-using, black men who have sex with men. AIDS Behav. 2011;15:1745-1754.CrossRefPubMed
37.
Zurück zum Zitat Stephenson R, Sullivan PS, Salazar LF, et al. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80-S87.CrossRefPubMedCentralPubMed Stephenson R, Sullivan PS, Salazar LF, et al. Attitudes towards couples-based HIV testing among MSM in three US cities. AIDS Behav. 2011;15(Suppl 1):S80-S87.CrossRefPubMedCentralPubMed
38.
Zurück zum Zitat CDC: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2014: A Clinical Practice Guideline, 2014. CDC: Preexposure Prophylaxis for the Prevention of HIV Infection in the United States 2014: A Clinical Practice Guideline, 2014.
Metadaten
Titel
Intimacy, Condom Use, and Pre-Exposure Prophylaxis (PrEP) Acceptability among Men Who Have Sex with Men (MSM) in Primary Partnerships: a Comment on Gamarel and Golub
verfasst von
Kristen Underhill, D. Phil., J. D.
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Annals of Behavioral Medicine / Ausgabe 2/2015
Print ISSN: 0883-6612
Elektronische ISSN: 1532-4796
DOI
https://doi.org/10.1007/s12160-014-9651-6

Weitere Artikel der Ausgabe 2/2015

Annals of Behavioral Medicine 2/2015 Zur Ausgabe

Neu in den Fachgebieten Neurologie und Psychiatrie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.